Searched for
PHARMA PATENT BATTLE
Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...- HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
- Natco wins patent battle to launch generic 'Risdiplam'A Delhi High Court ruling favors Natco Pharma against Roche's rare disease drug. Natco can now launch generic risdiplam, used for spinal mu...
- Dr Reddy's Labs launches copy of BI drug; move may lead to legal battleUnder its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....
- Taming the virus: Is a patent waiver on COVID vaccines the best option for the world?The forthcoming G20 meeting on October 30-31 in Rome should focus attention on these steps, instead of quietly acquiescing to the EU offer ...
- Poly Medicure wins long patent battle against German pharma giant B BraunThis could also bolster its case in some of the other European jurisdictions where it is defending patent infringement suits from the Germa...
- Rise in ex-parte orders upset generic drugmakers' future business plansCases where courts forbid Indian drugmakers from launching generic versions of patented drugs has rattled domestic pharma sector.
- Novartis loses legal battle over Glivec, huge boost for local drug cosNovartis' Glivec is priced at Rs 1.2 lakh whereas local generic versions, which feed most of the poor countries of the world, cost a fourth...
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Natco Pharma begins sales of Bristol Myers' cancer drug DasatinibHyderabad-based generic drugmaker Natco Pharma has started selling copies of global pharma major Bristol Myers Squibb's cancer drug Dasatin...
- Big pharma companies must allow generic firms to sell cheap HIV drugs to poor nationsAn independent mechanism that protects the patent rights of Big Pharma while allowing generic firms to sell cheap, copycat HIV drugs to poo...
- Hoffman La Roche loses patent suit against Matrix PharmaceuticalsRoche has lost a patent infringement suit against Matrix Pharma to prohibit the Indian firm from selling its anti-cancer drug Tarceva.
- Sun to stop making Alzheimer's drug after losing patent battleSun Pharma has lost patent battle for manufacturing and marketing of the generic version of Alzheimer's drug to US' Forest Laboratories.
- Novartis moves SC in Glivec patent caseSwiss major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board (IPAB) decision to reject its patent ...
- Pfizer charges Sun with another patent violationA legal battle between Pfizer and Sun Pharmaceutical has escalated.
- US firm drags Sun Pharma to court on StratteraUS drug giant Eli Lilly & Co has filed a patent infringement suit against Sun Pharmaceutical Industries to prevent the latter from selling ...
- Novartis warns India of losing R&D biz to ChinaMultinational drug makers would prefer China for investments in pharma research so long as India keeps the bar for patenting a drug so high...
- Wockhardt challenges patents litigationWockhardt Pharma has just got into the game. The co is challenging Abbott Lab patent on epilepsy drug.
- Local generic cos eye US windfallIndian generic pharma companies may now find it easier to challenge patents in the US. In another twist in the battle between innovators an...
- DRL expects verdict in Aciphex case by May 15As the patent clash between Dr Reddy's Labs (DRL) and Japanese pharma firm Eisai for the control over $1.3-billion anti-ulcer drug Aciphex ...
Load More
